SIC 3851 – Ophthalmic Goods
Valuation | |
---|---|
Market Cap ($M) | 17,896.02 |
Enterprise Value ($M) | 20,533.32 |
Book Value ($M) | 7,695.30 |
Book Value / Share | 38.72 |
Price / Book | 2.33 |
NCAV ($M) | -2,543.40 |
NCAV / Share | -12.80 |
Price / NCAV | -7.04 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.03 |
Return on Equity (ROE) | 0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.08 |
Current Ratio | 1.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,793.90 |
Assets | 12,032.60 |
Liabilities | 4,337.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 3,593.20 |
Operating Income | 561.80 |
Net Income | 294.20 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 607.50 |
Cash from Investing | -449.00 |
Cash from Financing | -173.90 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | T. Rowe Price Investment Management, Inc. | 3.70 | 0.00 | |
13G/A | Vanguard Group Inc | 11.57 | 2.67 | |
13G/A | BlackRock Inc. | 8.80 | 14.43 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
96,736 | 673,761 | 14.36 | |
112,535 | 629,662 | 17.87 | |
135,074 | 502,163 | 26.90 | |
174,438 | 414,670 | 42.07 | |
(click for more detail) |
Similar Companies |
---|
EYE – National Vision Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io